When Can We Expect A Profit From electroCore, Inc. (NASDAQ:ECOR)?

With the business potentially at an important milestone, we thought we'd take a closer look at electroCore, Inc.'s (NASDAQ:ECOR) future prospects. electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The US$89m market-cap company posted a loss in its most recent financial year of US$14m and a latest trailing-twelve-month loss of US$15m leading to an even wider gap between loss and breakeven. Many investors are wondering about the rate at which electroCore will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

electroCore is bordering on breakeven, according to the 5 American Medical Equipment analysts. They anticipate the company to incur a final loss in 2027, before generating positive profits of US$2.1m in 2028. Therefore, the company is expected to breakeven roughly 2 years from today. How fast will the company have to grow each year in order to reach the breakeven point by 2028? Working backwards from analyst estimates, it turns out that they expect the company to grow 73% year-on-year, on average, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

Given this is a high-level overview, we won’t go into details of electroCore's upcoming projects, though, keep in mind that generally a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

See our latest analysis for electroCore

One thing we would like to bring into light with electroCore is it currently has negative equity on its balance sheet. This can sometimes arise from accounting methods used to deal with accumulated losses from prior years, which are viewed as liabilities carried forward until it cancels out in the future. These losses tend to occur only on paper, however, in other cases it can be forewarning.

Next Steps:

This article is not intended to be a comprehensive analysis on electroCore, so if you are interested in understanding the company at a deeper level, take a look at electroCore's company page on Simply Wall St. We've also put together a list of pertinent factors you should further examine:

1. Valuation: What is electroCore worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether electroCore is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on electroCore’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.